查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1837165

泌尿系统设备市场：按产品类型、技术、应用和最终用户 - 全球预测 2025-2032

Urology Devices Market by Product Type, Technology, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年泌尿系统设备市场规模将成长至 918.8 亿美元，复合年增长率为 9.51%。

主要市场统计数据
基准年2024年 444.1亿美元
预计2025年 485.6亿美元
预测年份：2032年 918.8亿美元
复合年增长率（%） 9.51%

简要回顾泌尿系统医疗设备领域不断发展变化的趋势，包括人口结构变化、临床创新、监管环境变化以及基于价值的照护动态

当前泌尿系统医疗设备市场格局呈现多种因素交织，凸显了製定清晰策略的迫切性。人口结构朝着老化方向发展，临床指南对微创手术的支持不断升级，患者对更快康復和更高生活品质的期望也不断提升，这些因素共同改变了器械设计的重点。同时，临床医生和医疗保健提供者要求更强有力的临床证据、更精简的工作流程以及能够无缝整合到现有护理路径中的器械。

监管机构正在加强对安全性和上市后监管的审查，报销框架也更重视价值和疗效，而非手术量。这些因素，加上影像技术、能量碎石术和生物材料领域的快速成熟，正在加速产品的迭代週期。因此，从製造商到医疗保健提供相关人员必须在上市速度和可靠的临床检验之间取得平衡，以维护信任并确保产品被广泛采用。

最终，在这种环境下取得成功取决于将研发投资与务实的商业策略相结合，建立付款方和提供者的关係，以及设计出能够带来可衡量临床和经济效益的设备。透过专注互通性、临床人体工学和以患者为中心的治疗结果，公司可以调整其产品组合，以满足紧迫的临床需求，同时保持对新医疗模式的适应性。

从微创系统到数位诊断和整合手术平台，技术和临床变革时期正在重塑泌尿系统治疗途径

近年来，泌尿系统护理的交付方法和设备概念发生了革命性的变化。微型化和影像技术的进步使得微创诊断和治疗成为可能，降低了病患发病率，并促进了门诊手术的进行。同时，能量输送系统、雷射技术和主导结石管理工具正在拓展治疗方案，使临床医生能够提供更具针对性的干预措施。

随着整合软体、程序分析和远端监控增强术后护理并支持长期疗效评估，数位健康和​​数据主导方法也日益受到青睐。此外，在感染控制、灭菌物流和工作流程效率至关重要的手术环境中，人们明显倾向于使用一次性抛弃式。这一趋势与人们对可重复使用替代品的重新关注并存，这些替代品可以透过改进灭菌技术，以负责任的方式管理生命週期成本和环境因素。

同时，监管途径也在不断演变，以适应组合产品和器械-药物整合，例如涂药支架和抗菌涂层导管。因此，商业化策略越来越需要跨职能能力，包括临床研究、监管事务、供应链韧性和付款人参与。积极适应这一转变的相关人员将更有能力将技术前景转化为持续的临床应用。

评估 2025 年美国新关税对泌尿系统医疗设备供应链、筹资策略、成本和临床采购惯例的累积影响

2025年美国加征关税对全球供应链产生了连锁反应，直接影响了泌尿系统设备的采购决策、成本结构和采购惯例。严重依赖跨境零件采购的製造商面临投入成本上升和利润率压缩的双重压力，迫使许多製造商寻求多元化供应商、进行近岸外包，并重新评估库存策略。因此，医院、急诊医院和专科诊所的采购团队在评估供应商合约时面临越来越大的谈判压力，并重新关注整体拥有成本。

此外，关税促使产品系列重新调整。大批量耗材和低净利率器械面临越来越大的压力，需要在不影响临床性能的情况下实现本地化生产或重新设计以实现成本效益。为此，一些製造商优先考虑模组化平台和标准化组件，以缓解关税相关的价格波动，并加快与区域合约製造商的合作，以保持供应的连续性。这些转变也影响了一次性和可重复使用器械之间的策略平衡，因为决策者需要权衡初始资本成本、灭菌物流和持续耗材成本。

因此，临床医生和采购主管正在调整设备采用时间表和选择标准，强调可证明的效率和培训资源，以减少手术时间和资源利用率。展望未来，组织的韧性将取决于透明的供应商生态系统、灵活的合同，以及将成本压力转化为医疗服务提供者和患者差异化价值提案的能力。

对产品类型、技术、临床应用和最终用户的深入细分洞察，为有针对性的投资和商业化策略提供讯息

细緻的细分视角有助于明确投资和临床开发的重点。内视镜设备包括膀胱镜、肾臟镜和输尿管镜，它们的可视化能力和操作设定各不相同。结石处理设备包括雷射系统、碎石机和取石工具，它们的资本强度和操作人员训练要求各不相同。输尿管支架分为药物释放型支架、金属支架和聚合物支架，其通畅性和生物相容性各不相同。尿道导管包括外部导管、 Foley导管导尿管和间歇导尿管，每种导管都有其独特的感染控制和患者友善考虑因素。肌电图系统和压力流分析仪等尿动力学设备有助于提高诊断准确性并优化护理路径。

另外，抛弃式和可重复使用器械之间的技术划分对製造、灭菌物流和环境考量具有战略意义。抛弃式方案有助于在易受感染的环境中推广，并降低灭菌成本；而可重复使用系统，如果采用可靠的灭菌方案，则可以透过长期降低每次手术的耗材成本，从而证明更高的资本投资是合理的。

基于应用的细分突出了临床重点领域，例如良性前列腺增生、膀胱癌、肾结石、尿失禁和尿道感染，每个领域都有其独特的手术组合、后续治疗方案和设备设计限制。门诊手术中心、医院和泌尿系统诊所的终端使用者细分则突显了采购週期、资金可用性、手术量和培训资源的差异。这些细分指南产品开发优先顺序的确定、临床证据的产生以及与实际实践环境相符的上市倡议。

美洲、欧洲、中东和非洲以及亚太地区的区域动态和采用模式将重新定义製造、监管和市场进入

区域动态对创新采用、监管预期和商业策略有着巨大的影响。在美洲，医疗保健系统融合了集中采购和分散的医疗机构决策，强调清晰的临床经济证据、与医院系统的互通性以及强大的上市后支持。北美医疗保健提供者通常优先考虑程序效率和结果相关性，这推动了人们对减少住院时间和支持门诊医疗扩展的技术的兴趣。

欧洲、中东和非洲地区多样化的监管环境和报销模式既带来了复杂性，也带来了机会。该地区的一些国家青睐强有力的临床证据和已证实的成本效益，而另一些国家则透过专家卓越中心提供快速实施途径。本地製造能力和区域贸易框架也会影响采购决策，因此与区域经销商和契约製造製造商合作是任何打入市场策略的重要组成部分。

在亚太地区，由于医疗基础设施的快速现代化和资金匮乏的市场，其应用模式各有不同。高手术量和对微创治疗方案日益增长的需求，使得该地区对扩充性的设备平台和成本优化的耗材具有吸引力。在所有地区，关注培训、本地临床领导人物和供应链的可靠性对于实现持续应用和患者可近性至关重要。

领先泌尿系统设备公司的策略性企业行动和竞争定位，重点在于创新、伙伴关係、製造和临床证据策略

泌尿系统设备领域的主要企业正在采用多层面的策略来保持成长和临床相关性。许多公司优先考虑投资组合多元化，在高利润的资本设备与耗材的经常性收益之间取得平衡，从而稳定週期性需求。投资模式不仅注重核心设备效能，还注重相关功能，例如影像引导导航、数据分析和软体支援的工作流程，以提高临床医生的工作效率和病患治疗效果。

策略伙伴关係、授权协议和定向收购是加速取得专业技术、扩大临床覆盖范围和进入新地域市场的常用方法。同时，建立强大的临床证据计画和赞助研究者主导的研究对于与泌尿系统意见领袖和付款人建立信任仍然至关重要。製造弹性在企业计画中发挥关键作用，投资双重采购、品质系统和区域生产可以降低关税和库存风险。

在商业性，各公司正在透过专门的培训计划、流程支援和配套服务来优化其最终用户参与模式。这些措施有助于降低采用门槛，并实现更深层的临床整合。将卓越营运与专注的研发以及以临床医生为中心的竞争格局相结合的公司，将在快速发展的市场环境中保持长期竞争力。

为产业领导者提供实用且有影响力的建议，帮助他们应对供应中断、监管复杂性，并加速泌尿系统新技术的采用

产业领导者应采取一系列切实行动，将洞见转化为可衡量的成果。首先，寻求区域製造伙伴关係，以实现供应商多元化，增强对贸易中断的抵御能力，并缩短前置作业时间。此外，还应确保合约弹性，允许定价和交付条款反映不断变化的关税和物流环境。其次，优先投资于在门诊环境中具有成熟临床和经济价值的技术，例如精简的内视镜平台和可减轻灭菌负担和感染风险的一次性设备。

第三，它透过设计比较研究来衡量以患者为中心的治疗结果和总护理成本，从而增强临床证据的生成，从而提高付款方的参与度并促进基于价值的合约。第四，它利用数位医疗集成为医疗服务提供者提供程序分析和远端监控功能，以增强术后管理并支持患者的长期疗效。门诊手术中心致力于提高吞吐量，医院致力于提高整合系统和生命週期成本，专科诊所致力于提高设备的人体工学和易用性。

最后，透过全面的培训、模拟和程序支援专案投资于员工队伍的提升，可以减少部署过程中的摩擦。透过结合供应链的审慎性、循证驱动的研发以及临床导向的商业化，组织可以加速部署，同时最大限度地降低营运风险。

透明的调查方法，概述了用于获得泌尿系统可靠见解的主要访谈、二手资料、专家检验和三角测量技术

这些见解背后的调查方法以混合方法为中心，并专注于严谨性、透明度和三角测量。主要研究包括对临床医生、采购主管、监管专家和行业高管的结构化访谈，以了解该领域对临床需求、采购行为和应用障碍的观点。除了定性资讯外，我们还对同行评审的临床文献、监管指南文件和最佳实践进行了系统性回顾，以确保研究符合当代医疗标准。

为了检验和完善我们的研究结果，我们召集了一个专家小组，对假设进行质疑，并提供特定领域的细微差别。我们透过多个可用的独立资讯来源对定量资料点进行最后覆核，并运用敏感度分析来识别稳健趋势和瞬时市场噪音。我们根据临床工作流程、设备功能和最终用户特征建立了一个细分框架，以产生与实际决策相符的可行洞察。

品管包括迭代同侪审查、来源可追溯性和方法透明度，使相关人员能够评估结论的可靠性和适用性。在存在不确定性的情况下，明确强调考虑各种意外情况和情景，以支援策略规划和风险规避。

综合结论强调了泌尿系统医疗设备生态系统相关人员的策略机会、风险缓解和关键曲折点

总而言之，泌尿系统医疗设备的格局由多种因素共同决定：临床对微创、高效治疗的需求，推动精准医疗和数据整合的技术进步，以及来自供应链动态变化和报销模式演变的商业性压力。这些动态既带来了挑战，也带来了机会。在价值驱动型日益增强的环境中，那些投资于具有临床意义的创新、韧性供应链和实证商业化的公司将脱颖而出。

专注于产品类型、技术形式、临床应用和最终用户环境的细分，有助于更好地分配研发和上市资源。区域策略必须根据当地监管要求、采购行为和医疗保健基础设施量身定制，以确保成功进入市场并持续应用。最终，那些兼具营运纪律、临床伙伴关係和策略敏捷性的组织将最有能力将创新转化为改善的患者治疗效果和持续的商业性成功。

相关人员应将当前时期视为完善管道、增强供应弹性和深化临床参与的机会，以便下一代泌尿系统医疗设备的承诺能够在日常实践中实现。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 人工智慧驱动的成像演算法改善早期膀胱癌检测
  • 远端患者监护平台，优化慢性闭尿症管理
  • 可生物降解输尿管支架技术降低二次介入率
  • 使用机器人辅助系统进行单孔微创切除术
  • 感测器整合导管解决方案，用于对抗导管相关的尿道感染
  • 3D列印患者专用肾臟植入改善泌尿系统重组结果
  • 人工智慧预测分析可预测肾结石患者復发的风险

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第 8 章泌尿系统设备市场（依产品类型）

  • 排泄管理
    • 介入设备
    • 非侵入式设备
    • 阴茎人工替代物
  • 内视镜设备
    • 膀胱镜
    • 肾镜
    • 输尿管镜
  • 结石管理设备
    • 雷射系统
    • 石料破碎装置
    • 除石工具
  • 输尿管支架
    • 药物释放型支架
    • 金属支架
    • 聚合物支架
  • 导尿管
    • 外导管
    • Foley导管
    • 间歇导尿管
  • 动态装置
    • 肌电图系统
    • 压力和流量分析仪

第九章泌尿系统设备市场（按技术）

  • 一次性的
  • 可重复使用的

第 10 章泌尿系统设备市场（依应用）

  • 良性摄护腺增生
  • 膀胱癌
  • 肾结石
  • 尿失禁
  • 尿道感染

第 11 章泌尿系统设备市场（依最终用户）

  • 门诊手术中心
  • 医院
  • 泌尿系统诊所

第十二章泌尿系统设备市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章泌尿系统设备市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章泌尿系统设备市场（依国家）

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Boston Scientific Corporation
    • Johnson & Johnson
    • Olympus Corporation
    • Medtronic plc
    • Stryker Corporation
    • Teleflex Incorporated
    • Coloplast A/S
    • Cook Medical LLC
    • KARL STORZ SE & Co. KG
    • Richard Wolf GmbH
Product Code: MRR-034B50030338

The Urology Devices Market is projected to grow by USD 91.88 billion at a CAGR of 9.51% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 44.41 billion
Estimated Year [2025] USD 48.56 billion
Forecast Year [2032] USD 91.88 billion
CAGR (%) 9.51%

A concise introduction to the evolving urology devices landscape driven by demographics, clinical innovation, regulatory changes and value-based care dynamics

The contemporary landscape for urology devices is characterized by intersecting drivers that amplify the urgency for strategic clarity. Demographic shifts toward older populations, evolving clinical guidelines that favor minimally invasive procedures, and growing patient expectations for faster recovery and improved quality of life are collectively reshaping device design priorities. Concurrently, clinicians and healthcare providers are demanding stronger clinical evidence, streamlined workflows, and devices that integrate seamlessly into existing care pathways.

Regulatory agencies have intensified scrutiny on safety and post-market surveillance, while reimbursement frameworks increasingly prioritize value and outcomes over procedural volume. These forces, together with rapid technology maturation in imaging, energy-based lithotripsy, and biomaterials, are accelerating product iteration cycles. As a result, stakeholders from manufacturers to providers must balance speed to market with robust clinical validation to maintain trust and ensure adoption.

Ultimately, success in this environment depends on aligning R&D investments with pragmatic commercial strategies, cultivating payer and provider relationships, and designing devices that deliver measurable clinical and economic benefits. By focusing on interoperability, clinician ergonomics, and patient-centered outcomes, organizations can position their portfolios to address immediate clinical needs while remaining adaptable to emerging care models.

Transformative technological and clinical shifts reshaping urology care pathways from minimally invasive systems to digital diagnostics and integrated surgical platforms

Recent years have witnessed transformative shifts that are redefining how urology care is delivered and how devices are conceived. Advances in miniaturization and imaging are enabling less invasive diagnostics and therapies, reducing patient morbidity and facilitating procedures in ambulatory settings. At the same time, energy delivery systems, laser technologies, and precision-driven stone management tools are expanding therapeutic options and enabling clinicians to tailor interventions with greater specificity.

Digital health and data-driven approaches are also gaining traction, as integrated software, procedural analytics, and remote monitoring enhance postoperative care and support longitudinal outcome measurement. Furthermore, there is a clear movement toward single-use disposables in procedural environments where infection control, sterilization logistics, and workflow efficiency are paramount. This trend coexists with renewed interest in reusables where lifecycle cost and environmental considerations can be responsibly managed through improved sterilization technologies.

In parallel, regulatory pathways are evolving to better accommodate combination products and device-drug integrations, such as drug-eluting stents and antimicrobial-coated catheters. As a result, commercialization strategies increasingly rely on cross-functional capabilities that span clinical research, regulatory affairs, supply chain resilience, and payer engagement. Stakeholders that proactively adapt to these shifts will be better placed to convert technological promise into durable clinical adoption.

Assessing the cumulative effects of new United States tariffs in 2025 on urology device supply chains, sourcing strategies, costs and clinical procurement practices

The imposition of United States tariffs in 2025 created a ripple effect across global supply chains that directly affected sourcing decisions, cost structures, and procurement practices for urology devices. Manufacturers that relied heavily on cross-border component sourcing confronted elevated input costs and compressed margins, prompting many to reassess supplier diversification, nearshoring, and inventory strategies. As a consequence, procurement teams in hospitals, ambulatories, and specialty clinics faced tighter negotiations and a renewed emphasis on total cost of ownership when evaluating vendor contracts.

Moreover, the tariffs fostered a recalibration of product portfolios. High-volume consumables and devices with thin margins saw intensified pressure to localize manufacturing or to redesign for cost-effective production without compromising clinical performance. In response, several manufacturers prioritized modular platforms and standardized components to mitigate tariff-related price volatility, while others accelerated partnerships with regional contract manufacturers to preserve supply continuity. These shifts also influenced the strategic balance between disposable and reusable device offerings, with decision makers weighing the trade-offs between upfront capital costs, sterilization logistics, and ongoing consumable spend.

Clinicians and procurement leaders consequently adapted adoption timelines and device selection criteria, placing greater weight on demonstrable efficiencies and training resources that reduce procedural time and resource utilization. Looking forward, organizational resilience will depend on transparent supplier ecosystems, contractual flexibility, and the ability to translate cost pressures into differentiated value propositions for providers and patients.

Deep segmentation insights across product types, technologies, clinical applications and end users to inform targeted investment and commercialization strategies

A nuanced view of segmentation clarifies where investment and clinical development should be concentrated. Within product typology, continence management spans interventional devices, noninterventional devices, and penile prostheses, each responding to distinct clinical needs and reimbursement pathways; endoscopy devices include cystoscopes, nephroscopes, and ureteroscopes that differ by visualization capabilities and procedural settings; stone management devices encompass laser systems, lithotripsy devices, and stone removal tools that vary in capital intensity and operator training requirements; ureteral stents are differentiated across drug-eluting stents, metal stents, and polymer stents with divergent profiles for patency and biocompatibility; urinary catheters range from external catheters and Foley catheters to intermittent catheters each with unique infection control and patient usability considerations; and urodynamic devices such as EMG systems and pressure flow analyzers support diagnostic precision and care pathway optimization.

Separately, technology segmentation between disposable and reusable devices has strategic implications for manufacturing, sterilization logistics, and environmental considerations. Disposable solutions can accelerate adoption in infection-sensitive environments and reduce sterilization overhead, while reusable systems justify higher capital investment through lower per-procedure consumable costs over time when supported by robust sterilization protocols.

Application-based segmentation highlights clinical focus areas including benign prostatic hyperplasia, bladder cancer, kidney stones, urinary incontinence, and urinary tract infections, each presenting unique procedural mixes, follow-up regimens, and device design constraints. End-user segmentation across ambulatory surgical centers, hospitals, and urology clinics underscores variation in purchase cycles, capital availability, procedural throughput, and training resources. Together, these segmentation lenses guide prioritization of product development, clinical evidence generation, and go-to-market initiatives that align with real-world practice settings.

Regional dynamics and adoption patterns across the Americas, Europe Middle East & Africa and Asia-Pacific that are redefining manufacturing, regulation and market access

Regional dynamics exert a powerful influence on innovation adoption, regulatory expectations, and commercial strategy. In the Americas, healthcare systems display a mix of centralized procurement and fragmented provider decision making, which places a premium on clear clinical-economic evidence, interoperability with hospital systems, and robust post-market support. North American providers often prioritize procedural efficiency and outcomes linkage, driving interest in technologies that reduce length of stay and support ambulatory care expansion.

In Europe, Middle East & Africa, diverse regulatory landscapes and reimbursement models create both complexity and opportunity. Several countries in this region favor strong clinical evidence and cost-effectiveness demonstrations, while others offer pathways for rapid adoption through specialist centers of excellence. Local manufacturing capabilities and regional trade frameworks also influence sourcing decisions, making partnerships with regional distributors and contract manufacturers an essential part of market entry strategies.

Asia-Pacific presents heterogeneous adoption patterns driven by rapidly modernizing healthcare infrastructure in some markets and constrained capital in others. High procedure volumes and growing demand for minimally invasive options make the region attractive for scalable device platforms and cost-optimized consumables. Across all regions, attention to training, local clinical champions, and supply chain reliability remains essential to achieving durable adoption and patient access.

Strategic corporate behaviors and competitive positioning of leading urology device companies highlighting innovation, partnerships, manufacturing and clinical evidence strategies

Leading companies in the urology device space are adopting multifaceted strategies to sustain growth and clinical relevance. Many prioritize portfolio diversification that balances high-margin capital equipment with consumable recurring revenue, enabling stability through cyclical demand. Investment patterns emphasize not only core device performance but also adjacent capabilities such as image-guided navigation, data analytics, and software-enabled workflows that enhance clinician productivity and procedural outcomes.

Strategic partnerships, licensing agreements, and targeted acquisitions are common approaches to accelerate access to specialized technologies, broaden clinical reach, and enter new geographic markets. At the same time, establishing robust clinical evidence programs and sponsoring investigator-initiated studies remain central to building credibility with urology thought leaders and payers. Manufacturing resilience features prominently in corporate planning, with investments in dual sourcing, quality systems, and regional production to reduce tariff exposure and inventory risk.

Commercially, companies are optimizing their engagement models with end users by creating dedicated training programs, procedural support, and bundled service offerings. These moves help lower adoption barriers and create deeper clinical integration. Organizations that combine operational excellence with focused R&D and clinician-centric commercial strategies are best positioned to sustain long-term competitiveness in a rapidly evolving landscape.

Practical, high-impact recommendations for industry leaders to navigate supply disruptions, regulatory complexity and accelerate adoption of novel urology technologies

Industry leaders should adopt a set of pragmatic actions to translate insight into measurable outcomes. First, diversify supply sources and pursue regional manufacturing partnerships to enhance resilience against trade disruptions and to shorten lead times. This should be accompanied by contractual flexibility that allows pricing and delivery terms to reflect evolving tariff and logistics environments. Second, prioritize investments in technologies that demonstrate clear clinical and economic value in ambulatory settings, such as streamlined endoscopy platforms and single-use devices that reduce sterilization burden and infection risk.

Third, strengthen clinical evidence generation by designing comparative studies that measure patient-centered outcomes and total cost of care, thereby improving payer engagement and facilitating value-based contracting. Fourth, leverage digital health integration to offer providers procedural analytics and remote monitoring capabilities that enhance postoperative management and support long-term patient outcomes. Fifth, refine commercialization approaches by tailoring messaging and pricing to specific end users: ambulatory surgical centers will respond to throughput improvements, hospitals to integrated systems and lifecycle costs, and specialized clinics to device ergonomics and ease of use.

Finally, invest in workforce enablement through comprehensive training, simulation, and procedural support programs to reduce adoption friction. By combining supply chain prudence, evidence-focused R&D, and clinically aligned commercialization, organizations can accelerate adoption while minimizing operational risk.

Transparent research methodology outlining primary interviews, secondary sources, expert validation and triangulation techniques used to produce robust urology insights

The research approach underpinning these insights is anchored in a blended methodology that emphasizes rigor, transparency, and triangulation. Primary research included structured interviews with clinicians, procurement leaders, regulatory specialists, and industry executives to capture frontline perspectives on clinical needs, purchasing behavior, and adoption barriers. These qualitative inputs were complemented by a systematic review of peer-reviewed clinical literature, regulatory guidance documents, and procedural best practices to ensure alignment with contemporary standards of care.

To validate and refine findings, expert panels were convened to challenge assumptions and provide domain-specific nuance. Quantitative data points were cross-checked through multiple independent sources where available, and sensitivity analyses were applied to identify robust trends versus transient market noise. Segmentation frameworks were derived from clinical workflows, device functionality, and end-user characteristics to produce actionable insights that align with real-world decision making.

Quality control measures included iterative peer review, source traceability, and methodological transparency so stakeholders can assess the confidence and applicability of conclusions. Where uncertainty exists, the research explicitly highlights contingent factors and scenario considerations to support strategic planning and risk mitigation.

Concluding synthesis that highlights strategic opportunities, risk mitigations and the critical inflection points for stakeholders across the urology device ecosystem

In conclusion, the urology devices landscape is defined by converging forces: clinical demand for less invasive and more effective therapies, technological advances that enable precision care and data integration, and commercial pressures driven by supply chain dynamics and evolving reimbursement models. These dynamics create both challenges and opportunities. Organizations that invest in clinically meaningful innovation, resilient supply chains, and evidence-based commercialization will differentiate themselves in an increasingly value-focused environment.

Attention to segmentation-across product types, technology formats, clinical applications, and end-user settings-enables more precise allocation of R&D and go-to-market resources. Regional strategies must be tailored to local regulatory expectations, procurement behaviors, and healthcare infrastructure to ensure successful entry and sustained adoption. Ultimately, the organizations that combine operational discipline, clinical partnership, and strategic agility will be best positioned to convert innovation into improved patient outcomes and durable commercial success.

Stakeholders should view the current period as an opportunity to refine pipelines, fortify supply resilience, and deepen clinical engagement, so that the promise of next-generation urology devices is realized in everyday care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. AI-driven imaging algorithms improving early bladder cancer detection
  • 5.2. Remote patient monitoring platforms optimizing chronic urinary retention management
  • 5.3. Biodegradable ureteral stent technology reducing secondary intervention rates
  • 5.4. Robotic-assisted systems enabling single-port minimally invasive prostatectomy procedures
  • 5.5. Sensor-integrated catheter solutions tackling catheter-associated urinary tract infections
  • 5.6. 3D-printed patient-specific renal implants improving outcomes in reconstructive urology
  • 5.7. AI-powered predictive analytics forecasting stone recurrence risk in nephrolithiasis patients

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Urology Devices Market, by Product Type

  • 8.1. Continence Management
    • 8.1.1. Interventional Devices
    • 8.1.2. Noninterventional Devices
    • 8.1.3. Penile Prosthesis
  • 8.2. Endoscopy Devices
    • 8.2.1. Cystoscopes
    • 8.2.2. Nephroscopes
    • 8.2.3. Ureteroscopes
  • 8.3. Stone Management Devices
    • 8.3.1. Laser Systems
    • 8.3.2. Lithotripsy Devices
    • 8.3.3. Stone Removal Tools
  • 8.4. Ureteral Stents
    • 8.4.1. Drug Eluting Stents
    • 8.4.2. Metal Stents
    • 8.4.3. Polymer Stents
  • 8.5. Urinary Catheters
    • 8.5.1. External Catheters
    • 8.5.2. Foley Catheters
    • 8.5.3. Intermittent Catheters
  • 8.6. Urodynamic Devices
    • 8.6.1. EMG Systems
    • 8.6.2. Pressure Flow Analyzers

9. Urology Devices Market, by Technology

  • 9.1. Disposable
  • 9.2. Reusable

10. Urology Devices Market, by Application

  • 10.1. Benign Prostatic Hyperplasia
  • 10.2. Bladder Cancer
  • 10.3. Kidney Stones
  • 10.4. Urinary Incontinence
  • 10.5. Urinary Tract Infection

11. Urology Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals
  • 11.3. Urology Clinics

12. Urology Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Urology Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Urology Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Boston Scientific Corporation
    • 15.3.2. Johnson & Johnson
    • 15.3.3. Olympus Corporation
    • 15.3.4. Medtronic plc
    • 15.3.5. Stryker Corporation
    • 15.3.6. Teleflex Incorporated
    • 15.3.7. Coloplast A/S
    • 15.3.8. Cook Medical LLC
    • 15.3.9. KARL STORZ SE & Co. KG
    • 15.3.10. Richard Wolf GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL UROLOGY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. UROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL UROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL UROLOGY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERVENTIONAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NONINTERVENTIONAL DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PENILE PROSTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL UROLOGY DEVICES MARKET SIZE, BY CYSTOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL UROLOGY DEVICES MARKET SIZE, BY NEPHROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETEROSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL UROLOGY DEVICES MARKET SIZE, BY STONE REMOVAL TOOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DRUG ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL UROLOGY DEVICES MARKET SIZE, BY METAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL UROLOGY DEVICES MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EXTERNAL CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL UROLOGY DEVICES MARKET SIZE, BY FOLEY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL UROLOGY DEVICES MARKET SIZE, BY INTERMITTENT CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL UROLOGY DEVICES MARKET SIZE, BY EMG SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL UROLOGY DEVICES MARKET SIZE, BY PRESSURE FLOW ANALYZERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL UROLOGY DEVICES MARKET SIZE, BY DISPOSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REUSABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BENIGN PROSTATIC HYPERPLASIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL UROLOGY DEVICES MARKET SIZE, BY BLADDER CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL UROLOGY DEVICES MARKET SIZE, BY URINARY TRACT INFECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL UROLOGY DEVICES MARKET SIZE, BY UROLOGY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL UROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 231. AMERICAS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 232. AMERICAS UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 233. AMERICAS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 234. AMERICAS UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 252. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 253. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 254. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 274. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 292. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 293. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY URODYNAMIC DEVICES, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPE, MIDDLE EAST & AFRICA UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPE UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPE UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPE UROLOGY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPE UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPE UROLOGY DEVICES MARKET SIZE, BY CONTINENCE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 319. EUROPE UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2024 (USD MILLION)
  • TABLE 320. EUROPE UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPY DEVICES, 2025-2032 (USD MILLION)
  • TABLE 321. EUROPE UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2018-2024 (USD MILLION)
  • TABLE 322. EUROPE UROLOGY DEVICES MARKET SIZE, BY STONE MANAGEMENT DEVICES, 2025-2032 (USD MILLION)
  • TABLE 323. EUROPE UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2018-2024 (USD MILLION)
  • TABLE 324. EUROPE UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, 2025-2032 (USD MILLION)
  • TABLE 325. EUROPE UROLOGY DEVICES MARKET SIZE, BY URINARY CATHETERS, 2018-2024 (USD MILLION)

TABLE 3